Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer

• Published in: International urology and nephrology Vol. 55; no. 11; pp. 2733 - 2739
• Main Authors: Ihrig, Andreas, Pernt, Pascal Marino, Zschäbitz, Stefanie, Huber, Johannes, Friederich, Hans-Christoph, Bugaj, Till J., Maatouk, Imad
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.11.2023; Springer Nature B.V
• Subjects: Androgens; Antagonists; Cancer therapies; Chemotherapy; Clinical trials; Cognition; Cognitive ability; DRKS; DRKS00017727; Gonadotropin-releasing hormone; Luteinizing hormone; Medicine; Medicine & Public Health; Metastases; Metastasis; Nephrology; Patients; Prostate cancer; Sensorimotor integration; Urology; Urology - Original Paper; Hormonal agents; Metastatic prostate cancer; Androgen deprivation therapy; Neurocognitive effects

Introduction Although the growing treatment landscape for metastatic prostate cancer (mPC) has revealed new opportunities, it has also provided challenges, such as undesirable side effects. The aim of the present study was to provide further data on domain-specific cognitive impairments in mPC patie...